BioScrip (BIOS) Misses Q4 EPS by 70c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts BIOS Hot Sheet
Price: $10.80 --0%
Financial Fact:
Cost of revenue: 161.96M
Today's EPS Names:
FFBB, HFBL, RUSHA, More
Financial Fact:
Cost of revenue: 161.96M
Today's EPS Names:
FFBB, HFBL, RUSHA, More
Join SI Premium – FREE
BioScrip (NASDAQ: BIOS) reported Q4 EPS of ($0.69), $0.70 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $253.7 million versus the consensus estimate of $259.62 million.
For earnings history and earnings-related data on BioScrip (BIOS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ONEOK (OKE) Tops Q3 EPS by 63c; raises guidance
- FirstEnergy (FE) Tops Q3 EPS by 7c; offers guidance
- Baker Hughes Company (BKR) Tops Q3 EPS by 10c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
